Cargando…
Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF-β1/Smad3 signaling pathway
The present study aimed to assess the protective effect of epigallocatechingallate (EGCG) against myocardial injury in a mouse model of heart failure and to determine the mechanism underlying regulation of the transforming growth factor-β1/mothers against decapentaplegic homolog 3 (TGF-β1/Smad3) sig...
Autores principales: | Chen, Keyan, Chen, Wei, Liu, Shi Li, Wu, Tian Shi, Yu, Kai Feng, Qi, Jing, Wang, Yijun, Yao, Hui, Huang, Xiao Yang, Han, Ying, Hou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983962/ https://www.ncbi.nlm.nih.gov/pubmed/29620209 http://dx.doi.org/10.3892/mmr.2018.8825 |
Ejemplares similares
-
Dapagliflozin Attenuates Myocardial Fibrosis by Inhibiting the TGF-β1/Smad Signaling Pathway in a Normoglycemic Rabbit Model of Chronic Heart Failure
por: Chen, Xuefeng, et al.
Publicado: (2022) -
Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway
por: Ni, Jingyu, et al.
Publicado: (2017) -
2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway
por: Chen, Zhengjie, et al.
Publicado: (2022) -
Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021) -
MicroRNA-130a attenuates cardiac fibrosis after myocardial infarction through TGF-β/Smad signaling by directly targeting TGF-β receptor 1
por: Feng, Yu, et al.
Publicado: (2022)